Back to Market Feed

Product Information

COSENTYX 150 MG/ML SYRINGE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $7869.6275 per ML under NDC 00078063997. Its NADAC has been published 96 times since Oct 23, 2024.

COSENTYX 150 MG/ML SYRINGE

secukinumab
$7869.6275per ML

Strength

150 mg/mL

NDC

00078063997

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

SECUKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125504

On Market Since

1/21/2015

Pharmacological Classes

Interleukin-17A Antagonist
Interleukin-17A Antagonists

Price Statistics

The NADAC for COSENTYX 150 MG/ML SYRINGE has been published 96 times since Oct 23, 2024, and over the history we have for it it has risen 9.1%. The table below summarizes its recorded NADAC range and movement.

Current price$7869.6275 per ML
All-time high$7923.3134 (Jul 15, 2026)
All-time low$7204.2657 (Nov 20, 2024)
52-week high$7923.3134
52-week low$7385.6333
Median price$7422.9010
Average price$7551.4341
Largest weekly change+7.0% (Jan 14, 2026)
Weeks tracked96
Tracking sinceOct 23, 2024

Price History

1W

-0.1%

1M

-0.1%

3M

-0.7%

6M

-0.7%

1Y

+6.6%

3Y

N/A

5Y

N/A

All

+9.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 50%

1 alternative • Same active ingredient

COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES
Brand
00078063998•Novartis Pharmaceuticals Corporation
$3924.3531
Save 50%

Related Drugs

Same classification

TALTZ 80 MG/ML AUTOINJECTOR
Brand
00002144511•Eli Lilly and Company
$7373.5427
per ML
TALTZ 80 MG/ML AUTOINJECTOR (3-PACK)
Brand
00002144509•Eli Lilly and Company
$7388.2220
per ML
TALTZ 80 MG/ML SYRINGE
Brand
00002772411•Eli Lilly and Company
$7402.0679
per ML
TALTZ 80 MG/ML AUTOINJECTOR (2-PACK)
Brand
00002144527•Eli Lilly and Company
$7435.8708
per ML

Frequently asked questions

What is the NADAC price of COSENTYX 150 MG/ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for COSENTYX 150 MG/ML SYRINGE, manufactured by Novartis Pharmaceuticals Corporation, is $7869.6275 per ML (NDC 00078063997), effective Aug 19, 2026.

How has the price of COSENTYX 150 MG/ML SYRINGE changed over time?

Over the history we have for it, the NADAC for COSENTYX 150 MG/ML SYRINGE has risen 9.1%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for COSENTYX 150 MG/ML SYRINGE?

Since Oct 23, 2024, the NADAC for COSENTYX 150 MG/ML SYRINGE has ranged from a low of $7204.2657 (Nov 20, 2024) to a high of $7923.3134 (Jul 15, 2026), with a median of $7422.9010 per ML.

Are there cheaper alternatives to COSENTYX 150 MG/ML SYRINGE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES, is $3924.3531 per ML — about 50% below COSENTYX 150 MG/ML SYRINGE.

Who manufactures COSENTYX 150 MG/ML SYRINGE?

COSENTYX 150 MG/ML SYRINGE (NDC 00078063997) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.